LEMAITRE VASCULAR INC — Director's Dealing 2015

Oct 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2015-10-28

Reporting Person: Gebauer Peter R (President, International OP)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-28	Common Stock	M	7731	$7.10	Acquired	78151	Direct
2015-10-28	Common Stock	M	17805	$6.23	Acquired	95956	Direct
2015-10-28	Common Stock	M	12448	$6.80	Acquired	108404	Direct
2015-10-28	Common Stock	M	6331	$7.87	Acquired	114735	Direct
2015-10-28	Common Stock	S	44315	$13.97	Disposed	70420	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-28	Stock Option (Right to Buy)	$7.10	M	7731	Disposed	2018-07-26	Common Stock (7731)	Direct
2015-10-28	Stock Option (Right to Buy)	$6.23	M	17805	Disposed	2019-07-25	Common Stock (17805)	Direct
2015-10-28	Stock Option (Right to Buy)	$6.80	M	12448	Disposed	2020-08-07	Common Stock (12448)	Direct
2015-10-28	Stock Option (Right to Buy)	$7.87	M	6331	Disposed	2021-07-24	Common Stock (6331)	Direct

Footnotes

F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $13.90 to $14.18. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

F4: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.